These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 32017280
1. Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA. Rathitharan G, Truong J, Tong J, McCluskey T, Meyer JH, Mizrahi R, Warsh J, Rusjan P, Kennedy JL, Houle S, Kish SJ, Boileau I. Addict Biol; 2021 Jan; 26(1):e12876. PubMed ID: 32017280 [Abstract] [Full Text] [Related]
2. Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA. Suridjan I, Rusjan PM, Voineskos AN, Selvanathan T, Setiawan E, Strafella AP, Wilson AA, Meyer JH, Houle S, Mizrahi R. Neuroimage; 2014 Jan 01; 84():868-75. PubMed ID: 24064066 [Abstract] [Full Text] [Related]
3. Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA. Hafizi S, Da Silva T, Gerritsen C, Kiang M, Bagby RM, Prce I, Wilson AA, Houle S, Rusjan PM, Mizrahi R. Neuropsychopharmacology; 2017 Dec 01; 42(13):2474-2481. PubMed ID: 28604733 [Abstract] [Full Text] [Related]
4. Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA. Hafizi S, Tseng HH, Rao N, Selvanathan T, Kenk M, Bazinet RP, Suridjan I, Wilson AA, Meyer JH, Remington G, Houle S, Rusjan PM, Mizrahi R. Am J Psychiatry; 2017 Feb 01; 174(2):118-124. PubMed ID: 27609240 [Abstract] [Full Text] [Related]
6. Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA. Suridjan I, Rusjan PM, Kenk M, Verhoeff NP, Voineskos AN, Rotenberg D, Wilson AA, Meyer JH, Houle S, Mizrahi R. Synapse; 2014 Nov 01; 68(11):536-47. PubMed ID: 25043159 [Abstract] [Full Text] [Related]
7. Microglial activation in Parkinson's disease using [18F]-FEPPA. Ghadery C, Koshimori Y, Coakeley S, Harris M, Rusjan P, Kim J, Houle S, Strafella AP. J Neuroinflammation; 2017 Jan 11; 14(1):8. PubMed ID: 28086916 [Abstract] [Full Text] [Related]
11. Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder. Li H, Sagar AP, Kéri S. J Affect Disord; 2018 Dec 01; 241():305-310. PubMed ID: 30142589 [Abstract] [Full Text] [Related]
12. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, Suridjan I, Kennedy JL, Rekkas PV, Houle S, Meyer JH. JAMA Psychiatry; 2015 Mar 01; 72(3):268-75. PubMed ID: 25629589 [Abstract] [Full Text] [Related]
15. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [18F]LW223 as a TSPO-targeted PET radioligand. Tan Z, Haider A, Zhang S, Chen J, Wei J, Liao K, Li G, Wei H, Dong C, Ran W, Li Y, Li Y, Rong J, Li Y, Liang SH, Xu H, Wang L. Pharmacol Res; 2023 Mar 01; 189():106681. PubMed ID: 36746361 [Abstract] [Full Text] [Related]
19. Whole body biodistribution and radiation dosimetry in humans of a new PET ligand, [(18)F]-FEPPA, to image translocator protein (18 kDa). Mizrahi R, Rusjan PM, Vitcu I, Ng A, Wilson AA, Houle S, Bloomfield PM. Mol Imaging Biol; 2013 Jun 01; 15(3):353-9. PubMed ID: 22895910 [Abstract] [Full Text] [Related]